Drug News

Dermal Fillers Market Expected to Surge to USD 8.8 Billion by 2035

Roots Analysis has recently released a report projecting substantial growth in the global dermal fillers market, estimating its value to be USD 3.1 billion in 2023 and forecasting it to reach USD 8.8 billion by 2035. The market is expected to exhibit a Compound Annual Growth Rate (CAGR) of 9.18% during the forecast period from 2023 to 2035.

Dermal fillers, composed of hyaluronic acid and other materials, are becoming increasingly popular for facial rejuvenation, face lifting, lip enhancement, and scar treatment. The International Society of Aesthetic Plastic Surgery reported over 4.3 million hyaluronic acid dermal filler procedures worldwide in 2022, reflecting the widespread adoption of these minimally invasive solutions. The rising demand for such medical aesthetic procedures, driven by the desire for youthful skin and facial enhancements, is a key factor propelling the market’s growth.

Key Insights from the Report:

1.        Market Overview:

•          Estimated market value in 2023: USD 3.1 billion

•          Projected market value by 2035: USD 8.8 billion

•          Compounded Annual Growth Rate (CAGR): 9.18%

•          Forecast Period: 2023 – 2035

2.        Geographical Coverage:

•          North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America

3.        Market Drivers:

•          Minimally invasive nature of dermal filler injections attracting a broad population

•          Increasing demand from the aging population for procedures to achieve youthful skin

•          Influence of social media influencers contributing to market growth

•          Technological advancements, such as long-lasting formulations

4.        Market Restraints:

•          Risks of side effects such as bruising, swelling, and muscle weakness

•          Stringent regulations impacting the launch of novel formulations

•          High development costs associated with dermal fillers hindering market growth

5.        Growth Factors:

•          Opportunities for tailored formulations to meet aesthetic appearance requirements

•          Integration of advanced technologies like artificial intelligence, augmented reality, and virtual reality

•          Demand for biodegradable and sustainable materials driving innovation

Recent Developments:

•          Joint venture agreement between BioPlus and Chimin Health for hyaluronic acid-based dermal fillers in China

•          Collaboration between Pharmaresearch and Yxintent for the distribution of Rejuran Fillers in the Chinese market

•          Research and worldwide commercial partnership between Allergen Aesthetica and CollPlant for plant-based recombinant human collagen in connective and dermal tissue fillers

Market Segmentation:

•          Gender: Females led the dermal fillers market, capturing 90% of the market share in 2023, while males are expected to grow at the highest CAGR of 20.5%.

•          End User: Clinics/med spas and dermatology/cosmetology centers will dominate the market, capturing 50.0% of the share in 2023, with a higher CAGR of 9.57%.

•          Distribution: Indirect distribution led the market, capturing 80% of the market share in 2023, expected to grow at a higher CAGR of 11.7%.

Geographical Insights:

•          North America is anticipated to dominate the dermal fillers market, holding a significant share (48.4%) in 2023.

•          In Asia-Pacific, the market is likely to grow at a higher CAGR of 11.52% during the forecast period 2023-2035.

Key Companies Profiled:

•          Allergan Aesthetics

•          Alma Lasers

•          Biotechitalia

•          Bison Medical

•          Koru Pharma

•          MedicalZone

•          Merz Pharma

•          Mesoestetic

•          MesoTech

•          NeoGenesis

•          Sinclair Pharma

•          Xcelene

This comprehensive report aims to provide valuable insights for market leaders and newcomers alike, offering essential information on significant market drivers, barriers, opportunities, and challenges.


Joan David-Leonhard

Joan David Leonhard is a recent Pharm.D graduate with a strong passion for the pharmaceutical industry and a particular interest in pharmaceutical media and communication. Her brief internship experience includes roles in pharmacy where she built strong patient-pharmacist relationships and a pharmaceutical media internship where she actively contributed to drug information articles, blog posts, social media engagement, and various media projects.
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker